Literature DB >> 14996826

Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.

Paul Proost1, Sara Verpoest, Kirsten Van de Borne, Evemie Schutyser, Sofie Struyf, Willy Put, Isabelle Ronsse, Bernard Grillet, Ghislain Opdenakker, Jo Van Damme.   

Abstract

The synovial cavity constitutes the ideal stage to study the interplay between microbial Toll-like receptor (TLR) ligands and cytokines. Infiltrated leukocytes and synovial fibroblasts produce cytokine- and chemokine-induced proteases for remodeling the extracellular matrix. The regulation of chemokine function for attraction and activation of leukocytes constitutes a key feature in host immunity and resolution of inflammation after infection. Enhanced levels of the CXC chemokine ligand (CXCL9)/monokine induced by interferon-gamma (IFN-gamma) and CXCL11/IFN-inducible T cell alpha chemoattractant, two chemoattractants for activated T cells and natural killer cells, and ligands for CXC chemokine receptor 3 (CXCR3) were detected in the synovial fluid of septic arthritis compared with osteo- and crystal arthritis patients. In vitro, IFN-gamma and TLR3 ligation by double-stranded RNA (dsRNA) induced the expression of CXCL9 and CXCL11 in leukocytes and skin-muscle fibroblasts, whereas ligation of TLR2, TLR4, TLR5, and TLR9 by peptidoglycan (PGN), lipopolysaccharide (LPS), flagellin, and unmethylated CpG oligonucleotides, respectively, did not. PGN and LPS, but not unmethylated CpG oligonucleotides, even inhibited IFN-gamma-induced CXCL9 and CXCL11 expression in leukocytes. In sharp contrast, in fibroblasts, the TLR ligands PGN, dsRNA, LPS, and flagellin synergized with IFN-gamma for the production of CXCL9 and CXCL11. Although TLR ligands stimulate leukocytes to produce CXCL8/interleukin-8 during the early innate defense, they contribute less to the production of CXCR3 ligands, whereas fibroblasts are important sources of CXCR3 ligands. These results illustrate the complex interaction between cytokines and TLR ligands in infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996826     DOI: 10.1189/jlb.1003524

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  37 in total

Review 1.  Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis.

Authors:  T R D J Radstake; A W T van Lieshout; P L C M van Riel; W B van den Berg; G J Adema
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

Review 2.  Infectious disease, the innate immune response, and fibrosis.

Authors:  Alessia Meneghin; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

3.  Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis.

Authors:  Nicholas K Arger; Melissa Ho; Prescott G Woodruff; Laura L Koth
Journal:  Respir Med       Date:  2019-04-17       Impact factor: 3.415

Review 4.  Toll-Like Receptor Function in Acute Wounds.

Authors:  Lin Chen; Luisa A DiPietro
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

5.  The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.

Authors:  Vincent Vanheule; Rik Janssens; Daiane Boff; Nikola Kitic; Nele Berghmans; Isabelle Ronsse; Andreas J Kungl; Flavio Almeida Amaral; Mauro Martins Teixeira; Jo Van Damme; Paul Proost; Anneleen Mortier
Journal:  J Biol Chem       Date:  2015-07-16       Impact factor: 5.157

6.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy.

Authors:  Flobert Y Tanga; Nancy Nutile-McMenemy; Joyce A DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

7.  Poly(I:C) drives type I IFN- and TGFβ-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis.

Authors:  Giuseppina A Farina; Michael R York; Michael Di Marzio; Cindy A Collins; Stephan Meller; Bernhard Homey; Ian R Rifkin; Ann Marshak-Rothstein; Timothy R D J Radstake; Robert Lafyatis
Journal:  J Invest Dermatol       Date:  2010-07-08       Impact factor: 8.551

8.  Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease.

Authors:  Mercedes Gonzalez-Juarrero; Luke C Kingry; Diane J Ordway; Marcela Henao-Tamayo; Marisa Harton; Randall J Basaraba; William H Hanneman; Ian M Orme; Richard A Slayden
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-11       Impact factor: 6.914

9.  C/EBPbeta mediates synergistic upregulation of gene expression by interferon-gamma and tumor necrosis factor-alpha in bone marrow-derived mesenchymal stem cells.

Authors:  Guangwu Xu; Yingyu Zhang; Liying Zhang; Arthur I Roberts; Yufang Shi
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

10.  Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells.

Authors:  Helen M McGettrick; Emily Smith; Andrew Filer; Stephen Kissane; Michael Salmon; Christopher D Buckley; G Ed Rainger; Gerard B Nash
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.